Radiomics approaches have been developed to evaluate the prognosis in various tumors [17–21], and even to predict tumor-infiltrating CD8+ cells, response to ICI therapy and abscopal response of combining ICI therapy with RT [22, 23]. This evidence concerns the gene CD8A and neoplasm.